TP53 and neoplasm: We also found that several classic tumor-related pathways were enriched in the high-risk group, including the Hippo signaling pathway, NF-kappa B signaling pathway, p53 signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, and Ras signaling pathway (Figure 8B).